Sugammadex
Pronunciation: soo-GAM-a-dex
A selective relaxant binding agent that reverses aminosteroid neuromuscular blockade (rocuronium or vecuronium) by encapsulating the drug molecule.
Full Definition
Sugammadex is a modified gamma-cyclodextrin designed to encapsulate and inactivate rocuronium and vecuronium, producing rapid and predictable reversal of neuromuscular blockade regardless of depth. Unlike cholinesterase inhibitors such as neostigmine, sugammadex does not require co-administration of an anticholinergic agent, simplifying the reversal regimen and reducing bradycardia risk. In dental anesthesiology its availability in an office-based crash cart is increasingly recommended by specialty guidelines. Editors should note the lowercase 's' for the generic drug name and verify spelling against the approved INN (international nonproprietary name).
Usage
Usage note: Generic name is lowercase 'sugammadex'; brand name 'Bridion' takes a capital B. Do not confuse mechanism of action with that of neostigmine, which inhibits acetylcholinesterase.
In Context
- "Sugammadex 200 mg IV was administered to achieve full reversal of rocuronium-induced neuromuscular blockade within two minutes." — Anesthesia record
- "The office anesthesia protocol listed sugammadex alongside flumazenil and naloxone as mandatory reversal agents for the procedure room." — Office-based anesthesia inspection checklist